We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M Turnover 0%
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-16.59%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$29.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ABCL icon
1
AbCellera Biologics
ABCL
$3.8B
$128M 86.19%
3,773,530
– –
2020 Q4
1 quarter
CMPS icon
2
Compass Pathways
CMPS
$1.49B
$20.5M 13.81%
557,760
– –
2020 Q4
1 quarter

Similar funds

Founders Fund VII Management's Q1 2021 Portfolio in Review

As of Q1 2021, Founders Fund VII Management held 2 positions worth $149M, down 17% from $178M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Founders Fund VII Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's ten largest holdings make up 100% of its $149M portfolio in Q1 2021.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q1 2021.
  • Founders Fund VII Management's portfolio value fell 17% quarter-over-quarter to $149M.

Based on Founders Fund VII Management's 13F filing for Q1 2021, filed 17 May 2021.